Talleyrand IntelligenceThe facts. Your judgement.

The Cigna Group Q2 2026 — the filed record

CALL 2026-07-30 RECORD PUBLISHED 2026-08-18 FILING RECORD · TRANSCRIPT ANALYSIS PENDING
Source Statements — No Public Why FoundManagement is quoted · no explanatory analyst or media source was found
Management
Management · earnings release

Brian C. Evanko · earnings statement

“Our purpose is to improve the lives of each and every customer and patient we serve,”
Brian C. EvankoPresident and Chief Executive Officer of The Cigna Group8-K 2026-07-30 · EX-99.1 ↗
Target Changes — Why Not AvailableAction is public · model logic is not
Analyst action
Reported action · explanation unavailable

Cigna Group (NYSE:CI) Downgraded to "Outperform" Rating by Raymond James Financial

Why the target changed: not public. The linked report does not provide the analyst’s revised forecasts, valuation multiple, or assumptions. The results and guidance above may have informed the action, but the public record does not establish that connection.

Raymond James FinancialPost-earnings analyst actionMarketBeat 2026-08-03 ↗
Analyst action
Reported action · explanation unavailable

Cigna Group (NYSE:CI) Rating Lowered to Hold at Wall Street Zen

Why the target changed: not public. The linked report does not provide the analyst’s revised forecasts, valuation multiple, or assumptions. The results and guidance above may have informed the action, but the public record does not establish that connection.

Wall Street ZenPost-earnings analyst actionMarketBeat 2026-08-01 ↗
Sourced Takeaways4 takeaways · every bullet sourced
  1. Diluted EPS (GAAP) was $6.29; versus $5.71 a year earlier.
    Filed8-K 2026-07-30 · EX-99.1
  2. Adjusted EPS was $7.78; versus $7.20 a year earlier.
    Filed8-K 2026-07-30 · EX-99.1
  3. Revenue was $71.7B; +7% YoY.
    Filed8-K 2026-07-30 · EX-99.1
  4. Net income was $1.7B; versus $1.5B a year earlier.
    Filed8-K 2026-07-30 · EX-99.1
The NumbersReported · published precision · every figure sourced
MetricQ2 2026Prior yrYoYFY Guide
Diluted EPS (GAAP)$6.29$5.71
Adjusted EPS$7.78$7.20
Revenue$71.7B+7%
Net income$1.7B$1.5B
CMS ROWS ARE GROUND TRUTH, INDEPENDENT OF COMPANY REPORTING · PRECISION PER BRAND SPEC
The DocumentsEverything this record is built from
The filing every figure on this page is read from.
8-K 2026-07-30 · EX-99.1